English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#sarcomas search results

IntensityInc's profile picture. Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to create safer and more efficacious cancer therapies.
Intensity Therapeutics
@IntensityInc
Nov 18

#IntensityTherapeutics had a great time at the @ctosociety annual meeting with a large number of our Phase 3 investigators who are advancing care for rare and hard-to-treat #sarcomas. $INTS appreciated the chance to engage with other researchers, clinicians, & partners as we…

IntensityInc's tweet image. #IntensityTherapeutics had a great time at the @ctosociety annual meeting with a large number of our Phase 3 investigators who are advancing care for rare and hard-to-treat #sarcomas. $INTS appreciated the chance to engage with other researchers, clinicians, & partners as we…
1
2
20
0
2K
SantagataMDPhD's profile picture. Physician Scientist - Pathologist | @Harvard_Lab | @MGBpathology
Sandro Santagata
@SantagataMDPhD
Nov 7, 2024

Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,…

SantagataMDPhD's tweet image. Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,…
SantagataMDPhD's tweet image. Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,…
0
13
26
2
3K
MarioBalsaMD's profile picture. Galleguiño 🌊 | Medical Oncology resident at @ICO_oncologia | 2025 Rotation Resident Research at @MDAndersonNews 🇺🇸 | @OncoAlert team 💥 | Pianist 🎹
Mario Balsa
@MarioBalsaMD
Oct 18

🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…

MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
2
13
31
5
3K
mreyesm's profile picture. Director- Ped & Perinat Pathol. U Miami. Standing WHO Ed.B. Expert Editor WHO PAED5. Former Yale Professor 1994-2008; Former EIC @PedDevPath (2001-2016).
Miguel Reyes-Múgica
 @mreyesm
Nov 11

Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath

mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
0
5
21
3
785
Sohaib_faleh's profile picture. Surgical Oncologist #Sarcoma/#BreastCancer/Peritoneal disease- McGill Uni affiliated #FRCSC #ABS #CGSO picutres were taken by patients permission for education
Sohayb Faleh
 @Sohaib_faleh
Dec 12, 2023

#sarcomas are considered one of the most joyable surgeries One of which you need to plan very well and be very meticulous Start slow , believe in yourself and have faith in your training One of my first few cases as an attending and I’m enjoying it Exhausted though😅

Sohaib_faleh's tweet image. #sarcomas are considered one of the most joyable surgeries One of which you need to plan very well and be very meticulous Start slow , believe in yourself and have faith in your training One of my first few cases as an attending and I’m enjoying it Exhausted though😅
3
1
12
1
2K
JournalCancer's profile picture. An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
ACS Journal Cancer
 @JournalCancer
Oct 10

New & #OpenAccess | 5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue #sarcomas: Results from a prospective trial acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

JournalCancer's tweet image. New & #OpenAccess | 5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue #sarcomas: Results from a prospective trial acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert
0
5
13
4
1K
CureSarcoma's profile picture. SFA’s mission is to improve outcomes for people diagnosed with sarcoma to increase the number of survivors.
Sarcoma Foundation of America
@CureSarcoma
Oct 2

In case you missed it, the first webinar of our pediatric sarcoma series is now available on YouTube! Hear from Dr. Damon R. Reed, Dr. Katherine A. Janeway, and Care Partner and Advocate Jenny Sage as they discuss what makes pediatric #sarcomas unique. Link in bio. #curesarcoma…

CureSarcoma's tweet image. In case you missed it, the first webinar of our pediatric sarcoma series is now available on YouTube! Hear from Dr. Damon R. Reed, Dr. Katherine A. Janeway, and Care Partner and Advocate Jenny Sage as they discuss what makes pediatric #sarcomas unique. Link in bio. #curesarcoma…
0
1
2
1
200
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |
Italian Sarcoma Group
 @ItaSarcomaGroup
Apr 4

Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.

ItaSarcomaGroup's tweet image. Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.
ItaSarcomaGroup's tweet image. Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.
ItaSarcomaGroup's tweet image. Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.
0
5
12
0
556
FadiHaddad_MD's profile picture. Assistant Professor, Leukemia Department MD Anderson Cancer Center, Houston
Fadi Haddad, MD
 @FadiHaddad_MD
Jun 3, 2024

Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️

FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
0
8
16
0
966
DrCeSarcoma's profile picture. Physician-scientist · #sarcoma #GIST @VHIO | External Group Leader @IRBBarcelona | #SanidadPública | #SinCienciaNoHayFuturo | @MyEsmo Faculty. Tweets are my own
César Serrano García
 @DrCeSarcoma
Mar 21

💡 Neoadjuvant chemotherapy + immunotherapy in #sarcomas 👥 Select subtypes and stratify 💉Don’t focus only on ICIs - test new agents 🔬Include pathological response as an endpoint 📉Use novel trial designs Wonderful overview from Maud Toulmonde at #ESMORareCancers25

DrCeSarcoma's tweet image. 💡 Neoadjuvant chemotherapy + immunotherapy in #sarcomas 👥 Select subtypes and stratify 💉Don’t focus only on ICIs - test new agents 🔬Include pathological response as an endpoint 📉Use novel trial designs Wonderful overview from Maud Toulmonde at #ESMORareCancers25
DrCeSarcoma's tweet image. 💡 Neoadjuvant chemotherapy + immunotherapy in #sarcomas 👥 Select subtypes and stratify 💉Don’t focus only on ICIs - test new agents 🔬Include pathological response as an endpoint 📉Use novel trial designs Wonderful overview from Maud Toulmonde at #ESMORareCancers25
7
6
33
3
1K
imedverse's profile picture. Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News
Top Biomedical Science
 @imedverse
Feb 19, 2024

Use mnemonic "SCARE" to easily remember the five histologies of #sarcomas with lymph node involvement @OsmosisMed #MedEd #MedX

imedverse's tweet image. Use mnemonic "SCARE" to easily remember the five histologies of #sarcomas with lymph node involvement @OsmosisMed #MedEd #MedX
0
4
14
5
2K
srothschild's profile picture. Executive Director of @LifeRaftGroup
Sara Rothschild
 @srothschild
Nov 13, 2024

Love the engagement and ideas shared for the PUSH Project at #CTOS2024. The community needs to find ways to share data to help build future prospective studies for ultra rare #sarcomas

srothschild's tweet image. Love the engagement and ideas shared for the PUSH Project at #CTOS2024. The community needs to find ways to share data to help build future prospective studies for ultra rare #sarcomas
0
5
13
0
555
herbloong's profile picture. Academic medical oncologist @ Hong Kong w/ interests in sarcoma medical oncology, thoracic oncology & phase 1 trials | Disclosures: https://t.co/sb5XXrv5zx
Herbert Loong, MBBS, FASCO
@herbloong
Nov 4

Thanks @CureSarcoma for hosting yesterday's #webinar on (emerging) role of #ctDNA 🧬 in #sarcomas. A pleasure discussing this topic with renowned #sarcoma colleagues #DavidShulman & #EdwinChoy. Lots of interests and questions from the audience. Full video 📽️ can be found here:…

herbloong's tweet image. Thanks @CureSarcoma for hosting yesterday's #webinar on (emerging) role of #ctDNA 🧬 in #sarcomas. A pleasure discussing this topic with renowned #sarcoma colleagues #DavidShulman & #EdwinChoy. Lots of interests and questions from the audience. Full video 📽️ can be found here:…
herbloong's tweet image. Thanks @CureSarcoma for hosting yesterday's #webinar on (emerging) role of #ctDNA 🧬 in #sarcomas. A pleasure discussing this topic with renowned #sarcoma colleagues #DavidShulman & #EdwinChoy. Lots of interests and questions from the audience. Full video 📽️ can be found here:…
0
1
8
0
587
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |
Italian Sarcoma Group
 @ItaSarcomaGroup
Apr 12, 2024

Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale

ItaSarcomaGroup's tweet image. Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale
ItaSarcomaGroup's tweet image. Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale
ItaSarcomaGroup's tweet image. Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale
0
6
13
0
2K
LaceyPolice's profile picture. Partnering with the community to make Lacey a safe and desirable place to live, work, learn, and play. Replies will not be answered. Call 911 for emergencies.
Lacey Police
 @LaceyPolice
Jul 24, 2023

July is #SarcomaAwarenessMonth! #Sarcomas are rare cancers that develop in bones & soft tissue. It accounts for about 1% of cancers in adults, and is more commonly seen in children/teens. It is also difficult to detect.

LaceyPolice's tweet image. July is #SarcomaAwarenessMonth! #Sarcomas are rare cancers that develop in bones & soft tissue. It accounts for about 1% of cancers in adults, and is more commonly seen in children/teens. It is also difficult to detect.
1
1
2
0
586
GVAclinic's profile picture. Compte oficial del Departament de Salut València-Clínic-la Malva-rosa: Hospital Clínic Universitari de València
Hospital Clínic de València
 @GVAclinic
Sep 19

🏥El Hospital Clínico de València celebra la II Jornada SarcoMAS para visibilizar este tipo de cáncer 🔝🩺Contamos con un comité multidisciplinar especializado en #sarcomas que trabaja para un abordaje integral y personalizado #VOCESDELSARCOMA 🔗breu.gva.es/b/2eF9

GVAclinic's tweet image. 🏥El Hospital Clínico de València celebra la II Jornada SarcoMAS para visibilizar este tipo de cáncer 🔝🩺Contamos con un comité multidisciplinar especializado en #sarcomas que trabaja para un abordaje integral y personalizado #VOCESDELSARCOMA 🔗breu.gva.es/b/2eF9
GVAclinic's tweet image. 🏥El Hospital Clínico de València celebra la II Jornada SarcoMAS para visibilizar este tipo de cáncer 🔝🩺Contamos con un comité multidisciplinar especializado en #sarcomas que trabaja para un abordaje integral y personalizado #VOCESDELSARCOMA 🔗breu.gva.es/b/2eF9
GVAclinic's tweet image. 🏥El Hospital Clínico de València celebra la II Jornada SarcoMAS para visibilizar este tipo de cáncer 🔝🩺Contamos con un comité multidisciplinar especializado en #sarcomas que trabaja para un abordaje integral y personalizado #VOCESDELSARCOMA 🔗breu.gva.es/b/2eF9
GVAclinic's tweet image. 🏥El Hospital Clínico de València celebra la II Jornada SarcoMAS para visibilizar este tipo de cáncer 🔝🩺Contamos con un comité multidisciplinar especializado en #sarcomas que trabaja para un abordaje integral y personalizado #VOCESDELSARCOMA 🔗breu.gva.es/b/2eF9
0
8
11
0
623
ClinicaNavarra's profile picture. Hospital académico. Asistencia, investigación y docencia. Centrados en paciente desde 1962. Nos gusta la gente que se abraza a la vida y te levanta.
Clínica Universidad de Navarra
@ClinicaNavarra
Sep 18

🔴 EN DIRECTO | #CUNHealthyForum Conversamos sobre #sarcomas con el Dr. Fernando Lapuente (Cirugía General y Digestiva), el Dr. Jorge Gómez (Cirugía Ortopédica y Traumatología), Rocío López, #enfermera, y @GonzalodelPrado, moderador. Únete: youtube.com/live/qafVGm3in…

ClinicaNavarra's tweet image. 🔴 EN DIRECTO | #CUNHealthyForum Conversamos sobre #sarcomas con el Dr. Fernando Lapuente (Cirugía General y Digestiva), el Dr. Jorge Gómez (Cirugía Ortopédica y Traumatología), Rocío López, #enfermera, y @GonzalodelPrado, moderador. Únete: youtube.com/live/qafVGm3in…
2
0
2
0
2K
alegronchi's profile picture. Chair Sarcoma Service - Department of Surgery - National Cancer Institute - Milan - Italy.
Alessandro Gronchi
 @alegronchi
Oct 3, 2024

Here we are at the end of our 1st day of #robotic surgery for abdominal #sarcomas at @IstTumori. Exploring new modalities to improve quality of live of our patients while striving to maximize their oncologic outcome!@TARPSWG @ctosociety @ChirSarcomi_INT

alegronchi's tweet image. Here we are at the end of our 1st day of #robotic surgery for abdominal #sarcomas at @IstTumori. Exploring new modalities to improve quality of live of our patients while striving to maximize their oncologic outcome!@TARPSWG @ctosociety @ChirSarcomi_INT
4
9
41
2
2K
IntensityInc's profile picture. Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to create safer and more efficacious cancer therapies.
Intensity Therapeutics
@IntensityInc
Nov 18

#IntensityTherapeutics had a great time at the @ctosociety annual meeting with a large number of our Phase 3 investigators who are advancing care for rare and hard-to-treat #sarcomas. $INTS appreciated the chance to engage with other researchers, clinicians, & partners as we…

IntensityInc's tweet image. #IntensityTherapeutics had a great time at the @ctosociety annual meeting with a large number of our Phase 3 investigators who are advancing care for rare and hard-to-treat #sarcomas. $INTS appreciated the chance to engage with other researchers, clinicians, & partners as we…
1
2
20
0
2K
BibliotecaHUVH's profile picture. Biblioteca del Vall d’Hebron Barcelona Hospital Campus
BibliotecaHUVH
 @BibliotecaHUVH
Nov 18

Histopathological Response After Neoadjuvant #Chemotherapy for High-Risk Soft-Tissue #Sarcomas: A Secondary Analysis of a Randomized Clinical Trial jamanetwork.com/journals/jaman… #hvhebron #ap [Text complet] @JAMANetworkOpen

BibliotecaHUVH's tweet card. This secondary analysis of a randomized clinical trial evaluates the histopathological features associated with risk of recurrence that can be used to estimate outcomes in patients with high-risk...
Histopathological Response After Neoadjuvant Chemotherapy in Soft-Tissue Sarcomas
Source: jamanetwork.com
0
0
0
0
18
RecordatiRareES's profile picture. En Recordati Rare Diseases nos centramos en una minoría: los afectados por las #EnfermedadesRaras (poco frecuentes, minoritarias) #FocusedOnTheFew
Recordati Rare Diseases España
 @RecordatiRareES
Nov 17

💡 El proyecto ganador recibirá 250.000 € y será elegido por un panel internacional de expertos en enfermedades minoritarias 👩‍🔬 Abierta la convocatoria a jóvenes investigadores en #Sarcomas 📅 Plazo: 31 de enero de 2026 👉 Más info: lnkd.in/eevd67tN #RareDisease #RRD

RecordatiRareES's tweet image. 💡 El proyecto ganador recibirá 250.000 € y será elegido por un panel internacional de expertos en enfermedades minoritarias 👩‍🔬 Abierta la convocatoria a jóvenes investigadores en #Sarcomas 📅 Plazo: 31 de enero de 2026 👉 Más info: lnkd.in/eevd67tN #RareDisease #RRD
0
0
0
0
67
ctosociety's profile picture. Medical professionals and scientists from around the world connect, collaborate, and share knowledge, experiences, and research for the treatment of sarcomas.
CTOS
 @ctosociety
Nov 14

Updates on Complications after #XRT for #Retroperitoneal #Sarcomas from #STRASS trial PREOP RT is NOT Associated with increased major postoperative complications in patients with primary RPS #CTOS2025 @tarpswg @EORTC @socsurgonc @ESSOnews @tirottafabio

ctosociety's tweet image. Updates on Complications after #XRT for #Retroperitoneal #Sarcomas from #STRASS trial PREOP RT is NOT Associated with increased major postoperative complications in patients with primary RPS #CTOS2025 @tarpswg @EORTC @socsurgonc @ESSOnews @tirottafabio
0
7
18
0
1K
VJOncology's profile picture. The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm
VJ Oncology
@VJOncology
Nov 14

@FlorentPeyraud presents #CONgRAtS: the first trial validating TLS as a predictive biomarker in soft-tissue #sarcomas. TLS-positive patients benefited from PD-1–based immunotherapy. Watch ➡️ ow.ly/RPUf50XqEJ2 #ESMO25 #scmSM #CTSM #TrialUpdate #ImmunoOnc #Oncology @myESMO

VJOncology's tweet card. Florent Peyraud, MD, PhD, Institut Bergonié, Bordeaux, France, discusses the Phase II CONgRAtS trial (EudraCT 2019-002332-81), the first study to validate tertiary lymphoid structures (TLS) as a...
CONgRAtS: TLS-guided immunotherapy in soft-tissue sarcomas
Source: vjoncology.com
0
0
0
0
46
eaonc's profile picture. Biomarker-driven medical research involving adults who have or are at risk of developing cancer
ECOG-ACRIN Cancer Research Group
 @eaonc
Nov 12

.@immunosarc of @LurieCancer is leading EA7222, a randomized phase 3 trial of doxorubicin alone or in combination with pembrolizumab in patients with advanced UPS and related poorly differentiated #sarcomas. More here: bit.ly/EA7222 cc: @CureSarcoma

eaonc's tweet image. .@immunosarc of @LurieCancer is leading EA7222, a randomized phase 3 trial of doxorubicin alone or in combination with pembrolizumab in patients with advanced UPS and related poorly differentiated #sarcomas. More here: bit.ly/EA7222 cc: @CureSarcoma
0
1
1
0
264
mreyesm's profile picture. Director- Ped & Perinat Pathol. U Miami. Standing WHO Ed.B. Expert Editor WHO PAED5. Former Yale Professor 1994-2008; Former EIC @PedDevPath (2001-2016).
Miguel Reyes-Múgica
 @mreyesm
Nov 11

Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath

mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
0
5
21
3
785
SMEOMX's profile picture. Asociación no lucrativa dedicada a fomentar, divulgar los avances científicos y la enseñanza de la oncología.
Sociedad Mexicana de Oncología, A.C.
@SMEOMX
Nov 8

💪 Liposarcoma retroperitoneal: caso clínico de resección quirúrgica amplia con infiltración multiorgánica. 📄 Vol. 24, Suplemento 1 – Mexican Journal of Oncology 🔗 gamo-smeo.com/frame_esp.php?… #Liposarcoma #Retroperitoneo #Sarcomas #CirugíaOncológica #Oncología #Salud #SMeO

SMEOMX's tweet image. 💪 Liposarcoma retroperitoneal: caso clínico de resección quirúrgica amplia con infiltración multiorgánica. 📄 Vol. 24, Suplemento 1 – Mexican Journal of Oncology 🔗 gamo-smeo.com/frame_esp.php?… #Liposarcoma #Retroperitoneo #Sarcomas #CirugíaOncológica #Oncología #Salud #SMeO
0
0
0
2
174
GrupoGeis's profile picture. twitter oficial del Grupo Español de Investigación en Sarcomas
GEIS
 @GrupoGeis
Nov 5

¡Mañana, 6 de noviembre! 6ª edición del webinar “Sarcomas en Atención Primaria” De 16:30 a 17:45 h Inscríbete aquí 👉 us02web.zoom.us/webinar/regist… Organizan @GrupoGEIS y @SEMERGENap, con la colaboración de @Deciphera y @PharmaMar . #Sarcomas #AtenciónPrimaria

GrupoGeis's tweet image. ¡Mañana, 6 de noviembre! 6ª edición del webinar “Sarcomas en Atención Primaria” De 16:30 a 17:45 h Inscríbete aquí 👉 us02web.zoom.us/webinar/regist… Organizan @GrupoGEIS y @SEMERGENap, con la colaboración de @Deciphera y @PharmaMar . #Sarcomas #AtenciónPrimaria
0
1
2
0
226
SEOR_ESP's profile picture. Somos una sociedad científica que avanza hacia el abordaje integral del cáncer, donde TODOS sumamos. Junto al paciente en su día a día. #LaRadioterapiaCura
SEOR.es
@SEOR_ESP
Nov 4

Os informamos que el 25 de noviembre se celebrará la Jornada de #Sarcomas de #SEOR en la Clínica Universitaria de Navarra, Madrid.Más información e inscripciones: seor.es/jornadas/jorna… #oncologíaradioterápica #radioterapia #auladeformaciónSEOR

SEOR_ESP's tweet image. Os informamos que el 25 de noviembre se celebrará la Jornada de #Sarcomas de #SEOR en la Clínica Universitaria de Navarra, Madrid.Más información e inscripciones: seor.es/jornadas/jorna… #oncologíaradioterápica #radioterapia #auladeformaciónSEOR
0
1
1
0
206
QS_Barcelona's profile picture. Perfil del Hospital @quironsalud Barcelona, referente de la sanidad privada catalana desde hace más de 70 años.
Hospital Quirónsalud Barcelona
 @QS_Barcelona
Nov 4

Solo el 1% de los cánceres malignos en adultos son #sarcomas, pero eso no los hace menos importantes. ¡Detectarlos y tratarlos a tiempo puede marcar la diferencia! quironsalud.com/hospital-barce…

QS_Barcelona's tweet image. Solo el 1% de los cánceres malignos en adultos son #sarcomas, pero eso no los hace menos importantes. ¡Detectarlos y tratarlos a tiempo puede marcar la diferencia! quironsalud.com/hospital-barce…
0
3
4
0
189
herbloong's profile picture. Academic medical oncologist @ Hong Kong w/ interests in sarcoma medical oncology, thoracic oncology & phase 1 trials | Disclosures: https://t.co/sb5XXrv5zx
Herbert Loong, MBBS, FASCO
@herbloong
Nov 4

Thanks @CureSarcoma for hosting yesterday's #webinar on (emerging) role of #ctDNA 🧬 in #sarcomas. A pleasure discussing this topic with renowned #sarcoma colleagues #DavidShulman & #EdwinChoy. Lots of interests and questions from the audience. Full video 📽️ can be found here:…

herbloong's tweet image. Thanks @CureSarcoma for hosting yesterday's #webinar on (emerging) role of #ctDNA 🧬 in #sarcomas. A pleasure discussing this topic with renowned #sarcoma colleagues #DavidShulman & #EdwinChoy. Lots of interests and questions from the audience. Full video 📽️ can be found here:…
herbloong's tweet image. Thanks @CureSarcoma for hosting yesterday's #webinar on (emerging) role of #ctDNA 🧬 in #sarcomas. A pleasure discussing this topic with renowned #sarcoma colleagues #DavidShulman & #EdwinChoy. Lots of interests and questions from the audience. Full video 📽️ can be found here:…
0
1
8
0
587
eaonc's profile picture. Biomarker-driven medical research involving adults who have or are at risk of developing cancer
ECOG-ACRIN Cancer Research Group
 @eaonc
Oct 22

.@immunosarc of @LurieCancer is leading EA7222, a randomized phase 3 trial of doxorubicin alone or in combination with pembrolizumab in patients with advanced UPS and related poorly differentiated #sarcomas. More here: bit.ly/EA7222 cc: @CureSarcoma

eaonc's tweet image. .@immunosarc of @LurieCancer is leading EA7222, a randomized phase 3 trial of doxorubicin alone or in combination with pembrolizumab in patients with advanced UPS and related poorly differentiated #sarcomas. More here: bit.ly/EA7222 cc: @CureSarcoma
0
0
2
1
200
SEOR_ESP's profile picture. Somos una sociedad científica que avanza hacia el abordaje integral del cáncer, donde TODOS sumamos. Junto al paciente en su día a día. #LaRadioterapiaCura
SEOR.es
@SEOR_ESP
Oct 22

Os informamos que el próximo jueves 27 de noviembre SEOR celebrará la JORNADA DE SARCOMAS, en la Clínica Universitaria de Navarra, Madrid. Más información e inscripciones: seor.es/webinar/jornad… #Sarcomas #oncologíaradioterápica #radioterapia #cáncer

SEOR_ESP's tweet image. Os informamos que el próximo jueves 27 de noviembre SEOR celebrará la JORNADA DE SARCOMAS, en la Clínica Universitaria de Navarra, Madrid. Más información e inscripciones: seor.es/webinar/jornad… #Sarcomas #oncologíaradioterápica #radioterapia #cáncer
0
0
0
0
185
proyectoimperas's profile picture. IMPERAS | Estudio del IMPacto En supervivencia y calidad de vida de la Revisión centralizada del diagnóstico Anatomopatológico en Sarcomas de partes blandas
IMPERAS
 @proyectoimperas
Oct 21

El 2º Curso IMPERAS de Sarcomas 2025 reunió en Zaragoza a especialistas de toda España para profundizar en el diagnóstico de tumores formadores de hueso y cartílago. Gracias a todos los que lo hicisteis posible #IMPERAS #Sarcomas #Investigación #Patología

0
4
10
2
274
DrOrtizCruz's profile picture. Jefe Oncología Ortopédica: Hospital La Paz, Ruber Internacional, MDAndersonSpain. Director Bone and Soft Tissue Tumor Course Madrid. https://t.co/Pp63xAj9MN
Eduardo Ortiz Cruz
 @DrOrtizCruz
Oct 18

El Dr @javierDcastro es clave en mostrarnos la perseverancia en intentar curar y/o prolongar la supervivencia de nuestros pacientes con #cancer #sarcomas. Un orgullo trabajar con el en #hospitalLaPaz @_SEOM

_SEOM's profile picture. Somos una sociedad científica, referente en cáncer. Nuestra misión: mejorar la prevención, el diagnóstico, el tratamiento y el seguimiento del cáncer.
SEOM
@_SEOM
Oct 2

🔊El Dr. @javierDcastro, vicepresidente de SEOM y jefe de Sección de Oncología Médica del Hospital La Paz de Madrid, ha hecho hincapié, al recoger el premio de #LiderazgoSanitario, en que la #Oncología intenta cada día un mayor número de curaciones y que estas sean de calidad…

1
11
21
0
1K
0
1
6
0
171
sarcoma_mx's profile picture. Colaboración multidisciplinaria de especialistas en sarcomas para el avance y mejoría continua del tratamiento y calidad de vida de los pacientes 🇲🇽

Grupo Mexicano de Sarcomas

@sarcoma_mx
GpoSarcomas's profile picture.

Sarcomas

@GpoSarcomas
TumoresA's profile picture. Grupo de Trabajo de Tumores Mesenquimales y Sarcomas de la Asociación Española de Cirujanos

Tumores Mesenquimales y Sarcomas de la AEC

@TumoresA
sarcomas2013's profile picture.

mpho

@sarcomas2013
GSarcomas's profile picture. Grupo Argentino de Sarcomas de Partes Blandas y Óseos (GASPAR)

Grupo Argentino de Sarcomas

@GSarcomas
sarcomas_isc's profile picture.

ISC

@sarcomas_isc
GrupoSarco19009's profile picture.

Grupo Mexicano Sarcomas

@GrupoSarco19009
SarcomasHULP1's profile picture.

@SarcomasHULP

@SarcomasHULP1
sarcomas505's profile picture. ♧◇اللهم أتنا في الدنيا حسنة وفي الاخرة حسنة◇♧

خادمة الدين

@sarcomas505
ctosociety's profile picture. Medical professionals and scientists from around the world connect, collaborate, and share knowledge, experiences, and research for the treatment of sarcomas.

CTOS

@ctosociety
Sarcomassssss's profile picture. Insta: sarcomassssss

Sarcomas

@Sarcomassssss
SarcomasHGUGM's profile picture. Unidad de Referencia Nacional CSUR en #sarcoma https://t.co/pOpsfvGwa2 / Curso Anual de Actualización en Tumores del Aparato Locomotor #HospitalGregorioMarañon

Sarcomas Hospital Gregorio Marañón

@SarcomasHGUGM
Akosua_sapormaa's profile picture.

Akosua sarcomas

@Akosua_sapormaa
EquipoSarc69450's profile picture.

Equipo Comunicación Asociación Sarcomas de Galicia

@EquipoSarc69450
sarcomass5Eding's profile picture.

sarcomas Edinger

@sarcomass5Eding
sarcomas's profile picture.

Sarcomas Oncología quirúrgica

@sarcomas
sarcomas114440's profile picture.

sarcomas

@sarcomas114440
sarcomas71602's profile picture.

JEFATURA SARCOMAS

@sarcomas71602
Sarcomas13's profile picture.

Sarcomas

@Sarcomas13
GreekSarc's profile picture.

Hellenic Group of Sarcomas and rare tumors

@GreekSarc
LangenauLab's profile picture. Our research focused on identifying new therapies for pediatric leukemias, sarcomas and developing immune compromised zebrafish for cellular transplantation.

Langenau Lab

@LangenauLab
SarcomasHCSC's profile picture. Comité Multidisciplinar de Sarcomas y Tumores Mesenquimales del Hospital Clínico San Carlos de Madrid. Cuenta profesional. #somosclinico

CSUR Sarcomas Hospital Clínico San Carlos

@SarcomasHCSC
GrupoGeis's profile picture. twitter oficial del Grupo Español de Investigación en Sarcomas

GEIS

@GrupoGeis
jh_zaldarriaga's profile picture. Radiation Oncology | Coffee | Music | Cats | Research interests: GI cancers, sarcomas, psychosocial oncology

Jose Ma. Zaldarriaga 🇵🇭

@jh_zaldarriaga
SarcomasHULP's profile picture. Unidad multidisciplinar experta en el diagnóstico y tratamiento de los tumores óseos y de partes blandas en adultos y niños. CSUR Sarcomas infantiles

Sarcomas Hospital La Paz

@SarcomasHULP
BenNacev's profile picture. Studying #chromatin dysregulation in #sarcomas and other tumors @UPMCHillmanCC | Goal = better treatments alum: MSK, Rockefeller, Hopkins med/Osler residency

Ben Nacev, MD PhD

@BenNacev
Sarcomas12's profile picture. montañismo

Sarcomas

@Sarcomas12
APConley77's profile picture. Sarcoma Specialist at MDACC, Research of rare cancers: pleomorphic sarcomas, ASPS, #chordomas, & #chondrosarcomas. Views are mine. #sarcoma

Anthony P Conley

@APConley77
MSKSarcoma's profile picture. For more than 135 years, we have been united by a singular purpose: to find cures for sarcomas. 1-844-923-0361 (new pts) | ReferAPatient@mskcc.org (doctors)

Sarcoma Service at Memorial Sloan Kettering

@MSKSarcoma
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |

Italian Sarcoma Group

@ItaSarcomaGroup
AjayGuptaMD1's profile picture. AYA Oncologist @RoswellPark @OCHBuffalo interested in sarcomas and developmental therapeutics. Likes fiction, Buddhism, music, travel, and sweets.

Ajay Gupta MD

@AjayGuptaMD1
SoftSarcoma's profile picture. Our goals are to understand the biology of pediatric sarcomas, generate new models and provide better therapeutic strategies for sarcoma patients.

Banito Lab

@SoftSarcoma
EmilySlotkin's profile picture. MSK Kids, Pediatric Sarcoma Service | DSRCT, Ewing and other AYA sarcomas | Memorial Sloan Kettering Cancer Center

Emily Slotkin

@EmilySlotkin
SRGIDIBELL's profile picture. We fight for sarcoma cure since 2009

Sarcomas IDIBELL

@SRGIDIBELL
SelnetH2020's profile picture. SELNET aims to improve the diagnosis and clinical care of sarcomas through a European and Latin American network. SELNET has received funds from the EU H2020

Sarcoma European LatinAmerican Network (SELNET)

@SelnetH2020
asargasarcoma's profile picture. Asociación para pacientes y familiares de cáncer Sarcoma | ¡Súmate a nosotr@s! 🎥 Documental 'El Sarcoma Día a Día': https://t.co/Ncd1rIIFGv

Asociación Sarcomas Grupo Asistencial 🎗

@asargasarcoma
KendallLabNCH's profile picture. PI @nationwidekids and Assistant Professor @OhioState; studying pediatric sarcomas using zebrafish genetic models and patient genomic data. Views are mine.

Genevieve Kendall, Ph.D.

@KendallLabNCH
fantinegiap's profile picture. Radiation Oncologist treating sarcomas at @MayoClinic | she/her | tweets = mine.

Fantine Giap

@fantinegiap
SweetCorderoLab's profile picture. Lung cancer & pediatric sarcomas: functional genomics, synthetic vulnerabilities, GEMMs, metastasis models. Account run by Labbies and @ASweetCordero.

Sweet-Cordero Lab @ UCSF

@SweetCorderoLab
sarcomasiolr's profile picture. Informacion y participacion en las actividades docentes del Postgrado de Cirugía Oncologica del Instituto Oncologico Luis Razetti

Melanomas y Sarcomas

@sarcomasiolr
DrLaraDavis's profile picture. OHSU Knight Cancer Institute Sarcoma Program Director. Focused on bone sarcomas and sarcomas in adolescents & young adults (AYAs). #OHSUSarcoma

Lara Davis

@DrLaraDavis
SarcomasAEC's profile picture. Cuenta de la Sección de Tumores Mesenquimales y Sarcomas de la AEC.

AEC Sarcomas

@SarcomasAEC
EpBeadle's profile picture. Cancer Biology at Vanderbilt University studying hedgehog signaling in sarcomas . Tweets are my own opinions.

Erik Beadle, Ph.D.

@EpBeadle
UTHSCSASarcoma's profile picture. Twitter page for the UTHSCSA Orthopaedic Oncology. Stay up to date on bone and soft tissue sarcomas along with benign, malignant, and metastatic disease.

UTHSA Sarcoma

@UTHSCSASarcoma
TulpuleLab's profile picture. Pediatric oncologist and Physician-Scientist at MSKCC. Receptor tyrosine kinase (RTK) fusions and condensates in cancer. DNA repair. Pediatric sarcomas.

Tulpule Lab

@TulpuleLab
RazaSayyed12's profile picture. Surgical Oncologist. Soft Tissue Sarcomas, Peritoneal Surface Malignancies, GI Cancers.

Raza Sayyed

@RazaSayyed12
LabHuvr's profile picture. Focused on the molecular basis of sarcomas and its application to patient care @ibis_sevilla @HospitalUVRocio @CIBERONC @unisevilla @GrupoGeis @Medicina_US

deAlava Lab_IBiS_HUVR #SinCienciaNoHayFuturo

@LabHuvr
Thalcin's profile picture. Oncologue médical/Hématologue, sarcomes et tumeurs digestives|Medical oncologist/Hematologist, sarcomas and GI |@danafarbernews and @harvardmed

Thierry Alcindor, MD, MSc

@Thalcin
cascalescirugia's profile picture. Jefe de la Sección de Cirugía Oncológica Peritoneal, Tumores Mesenquimales y Sarcomas (HCUVA) Catedrático de Cirugía (Universidad de Murcia)

Pedro Cascales

@cascalescirugia
aredondo12's profile picture. Oncólogo, dedicado a pacientes con tumores ginecológicos y sarcomas. Pasión por la naturaleza, música y básket.

Andrés Redondo

@aredondo12
MarioBalsaMD's profile picture. Galleguiño 🌊 | Medical Oncology resident at @ICO_oncologia | 2025 Rotation Resident Research at @MDAndersonNews 🇺🇸 | @OncoAlert team 💥 | Pianist 🎹
Mario Balsa
@MarioBalsaMD
Oct 18

🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…

MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
MarioBalsaMD's tweet image. 🦴 #ESMO25 #Sarcomas – MANEUVER ph III trial of pimicotinib in TGCT (n=63): 🎯ORR (BIRC) 76.2% | ORR (TVS): 74.6% ⏱ Median DOR: not reached ▪️Sustained tumor response, improved motion, and well tolerated When it comes to TGCT, pimicotinib didn’t just move the needle…it moved…
2
13
31
5
3K
SantagataMDPhD's profile picture. Physician Scientist - Pathologist | @Harvard_Lab | @MGBpathology
Sandro Santagata
@SantagataMDPhD
Nov 7, 2024

Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,…

SantagataMDPhD's tweet image. Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,…
SantagataMDPhD's tweet image. Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,…
0
13
26
2
3K
imedverse's profile picture. Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News
Top Biomedical Science
 @imedverse
Feb 19, 2024

Use mnemonic "SCARE" to easily remember the five histologies of #sarcomas with lymph node involvement @OsmosisMed #MedEd #MedX

imedverse's tweet image. Use mnemonic "SCARE" to easily remember the five histologies of #sarcomas with lymph node involvement @OsmosisMed #MedEd #MedX
0
4
14
5
2K
Sohaib_faleh's profile picture. Surgical Oncologist #Sarcoma/#BreastCancer/Peritoneal disease- McGill Uni affiliated #FRCSC #ABS #CGSO picutres were taken by patients permission for education
Sohayb Faleh
 @Sohaib_faleh
Dec 12, 2023

#sarcomas are considered one of the most joyable surgeries One of which you need to plan very well and be very meticulous Start slow , believe in yourself and have faith in your training One of my first few cases as an attending and I’m enjoying it Exhausted though😅

Sohaib_faleh's tweet image. #sarcomas are considered one of the most joyable surgeries One of which you need to plan very well and be very meticulous Start slow , believe in yourself and have faith in your training One of my first few cases as an attending and I’m enjoying it Exhausted though😅
3
1
12
1
2K
ExtracellMatrix's profile picture. An online resource for the extracellular matrix and tissue engineering research community. Part of the @STEMCELLTech Science News service.
Extracellular Matrix News
@ExtracellMatrix
Jun 1, 2024

Soft tissue #sarcomas comprise heterogeneous ECM signalling networks and matrix-specific features could have utility for risk stratification and therapy selection, reports an @ICR_London team including Drs. Valeriya Pankova and Paul Huang. bit.ly/3ViAby1

ExtracellMatrix's tweet image. Soft tissue #sarcomas comprise heterogeneous ECM signalling networks and matrix-specific features could have utility for risk stratification and therapy selection, reports an @ICR_London team including Drs. Valeriya Pankova and Paul Huang. bit.ly/3ViAby1
ExtracellMatrix's tweet image. Soft tissue #sarcomas comprise heterogeneous ECM signalling networks and matrix-specific features could have utility for risk stratification and therapy selection, reports an @ICR_London team including Drs. Valeriya Pankova and Paul Huang. bit.ly/3ViAby1
0
3
7
1
1K
montieljf's profile picture. Chief of Trauma and Emergency Surgery Unit. HBP & Sarcoma Surgery. European Board on Emergency Surgery and on HPB Surgery. Fundacion Jiménez Díaz Univ. Hospital
Montiel Jiménez, MD., PhD., FEBS EmSurg, FEBS HPB
 @montieljf
Apr 4

Aprendiendo en la Reunión Nacional de #sarcomas con los cirujanos hispano-lusos más 🔝🔝🔝. Aprendiendo con la @SarcomasAEC de la @aecirujanos @JmasencioJose @nadiahindi83 @BrotoJavier @Hospital_FJD @GarciaOlmoD

montieljf's tweet image. Aprendiendo en la Reunión Nacional de #sarcomas con los cirujanos hispano-lusos más 🔝🔝🔝. Aprendiendo con la @SarcomasAEC de la @aecirujanos @JmasencioJose @nadiahindi83 @BrotoJavier @Hospital_FJD @GarciaOlmoD
0
2
18
0
750
IntensityInc's profile picture. Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to create safer and more efficacious cancer therapies.
Intensity Therapeutics
@IntensityInc
Nov 18

#IntensityTherapeutics had a great time at the @ctosociety annual meeting with a large number of our Phase 3 investigators who are advancing care for rare and hard-to-treat #sarcomas. $INTS appreciated the chance to engage with other researchers, clinicians, & partners as we…

IntensityInc's tweet image. #IntensityTherapeutics had a great time at the @ctosociety annual meeting with a large number of our Phase 3 investigators who are advancing care for rare and hard-to-treat #sarcomas. $INTS appreciated the chance to engage with other researchers, clinicians, & partners as we…
1
2
20
0
2K
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |
Italian Sarcoma Group
 @ItaSarcomaGroup
Apr 4

Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.

ItaSarcomaGroup's tweet image. Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.
ItaSarcomaGroup's tweet image. Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.
ItaSarcomaGroup's tweet image. Day 2 of #ISG2025 opened with a dynamic and constructive session on localized soft tissue #sarcomas.From ILP in limb sarcomas to pelvic surgery strategies, and a lively debate on preop pembrolizumab + RT in UPS & DDLPS G3, #ISG members engaged in a rich exchange of perspectives.
0
5
12
0
556
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |
Italian Sarcoma Group
 @ItaSarcomaGroup
Apr 12, 2024

Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale

ItaSarcomaGroup's tweet image. Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale
ItaSarcomaGroup's tweet image. Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale
ItaSarcomaGroup's tweet image. Brilliant summary of cellular therapy at #ISG 🌟 Lecture of Dr. @Caruana_Ignazio from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment. @merlini_ale
0
6
13
0
2K
mreyesm's profile picture. Director- Ped & Perinat Pathol. U Miami. Standing WHO Ed.B. Expert Editor WHO PAED5. Former Yale Professor 1994-2008; Former EIC @PedDevPath (2001-2016).
Miguel Reyes-Múgica
 @mreyesm
Nov 11

Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath

mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
mreyesm's tweet image. Dr. @JLHornick delivering a masterful conference on #IHC on #sarcomas incorporating classic and contemporary advances. #Pathology #BSTPath #PediPath
0
5
21
3
785
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |
Italian Sarcoma Group
 @ItaSarcomaGroup
Apr 11, 2024

☢️ Debating the role of preoperative #radiotherapy in high risk #sarcomas ‼️Splitted medical community: maybe not for all pts? 🟢 Informed decision making and tailored treatments are the key to optimize patients outcomes and quality of life @alegronchi @FedeNavarria #isg

ItaSarcomaGroup's tweet image. ☢️ Debating the role of preoperative #radiotherapy in high risk #sarcomas ‼️Splitted medical community: maybe not for all pts? 🟢 Informed decision making and tailored treatments are the key to optimize patients outcomes and quality of life @alegronchi @FedeNavarria #isg
ItaSarcomaGroup's tweet image. ☢️ Debating the role of preoperative #radiotherapy in high risk #sarcomas ‼️Splitted medical community: maybe not for all pts? 🟢 Informed decision making and tailored treatments are the key to optimize patients outcomes and quality of life @alegronchi @FedeNavarria #isg
ItaSarcomaGroup's tweet image. ☢️ Debating the role of preoperative #radiotherapy in high risk #sarcomas ‼️Splitted medical community: maybe not for all pts? 🟢 Informed decision making and tailored treatments are the key to optimize patients outcomes and quality of life @alegronchi @FedeNavarria #isg
0
5
12
0
538
ItaSarcomaGroup's profile picture. ISG Ente Terzo Settore | Nonprofit group of professionals, since 1997 | Research in #sarcomas🎗| Trial Center | NetWorking for quality of care and life |
Italian Sarcoma Group
 @ItaSarcomaGroup
Apr 12, 2024

Discussing the main criticisms on drug access for #sarcomas with input from #ISG, patients and #AIFA. 🗣️ We need more dialogue with regulators to overcome barriers!! #drugaccess @SilviaStacchia @EheItalia @dackar77 @EheItalia @CelesteCagnazzo @annamariafrezza

ItaSarcomaGroup's tweet image. Discussing the main criticisms on drug access for #sarcomas with input from #ISG, patients and #AIFA. 🗣️ We need more dialogue with regulators to overcome barriers!! #drugaccess @SilviaStacchia @EheItalia @dackar77 @EheItalia @CelesteCagnazzo @annamariafrezza
ItaSarcomaGroup's tweet image. Discussing the main criticisms on drug access for #sarcomas with input from #ISG, patients and #AIFA. 🗣️ We need more dialogue with regulators to overcome barriers!! #drugaccess @SilviaStacchia @EheItalia @dackar77 @EheItalia @CelesteCagnazzo @annamariafrezza
ItaSarcomaGroup's tweet image. Discussing the main criticisms on drug access for #sarcomas with input from #ISG, patients and #AIFA. 🗣️ We need more dialogue with regulators to overcome barriers!! #drugaccess @SilviaStacchia @EheItalia @dackar77 @EheItalia @CelesteCagnazzo @annamariafrezza
0
7
16
0
2K
londonhead_neck's profile picture. Head & Neck Reconstructive Surgeon UCLH and Harley Street Clinic; Striving for best head and neck services in London.. President EACMFS
Nick Kalavrezos
 @londonhead_neck
Sep 18, 2024

And just completed a wonderful session on H & N sarcomas. Top class colleagues led by Prof Valentini in a packed lecture hall. Thank you! #sarcomas; #OMFS; #EACMFS

londonhead_neck's tweet image. And just completed a wonderful session on H & N sarcomas. Top class colleagues led by Prof Valentini in a packed lecture hall. Thank you! #sarcomas; #OMFS; #EACMFS
0
2
10
0
657
aecirujanos's profile picture. La Asociación Española de Cirugía es una sociedad médico-científica que tiene como finalidad contribuir al progreso de la cirugía.
aecirujanos
 @aecirujanos
May 10, 2024

Inauguración oficial del #IIIEncuentrohispanolusosarcomas con la presidenta @elenamartin2222 Os esperamos a todos en una jornada emocionante de formación y actualización multidisciplinar en #sarcomas @sarcomasAEC @GrupoGeis @SelnetH2020 @JmasencioJose

aecirujanos's tweet image. Inauguración oficial del #IIIEncuentrohispanolusosarcomas con la presidenta @elenamartin2222 Os esperamos a todos en una jornada emocionante de formación y actualización multidisciplinar en #sarcomas @sarcomasAEC @GrupoGeis @SelnetH2020 @JmasencioJose
1
6
12
0
937
CelsoMello15's profile picture. Medical Oncologist at A.C. Camargo Cancer Center, São Paulo, Brasil. Focus on GI and Sarcoma. SELNET member.
Celso Mello
 @CelsoMello15
Jun 5, 2023

Cabozantinib combinations for #sarcomas treatment presented #ASCO23. Promising data for #angiosarcoma.

CelsoMello15's tweet image. Cabozantinib combinations for #sarcomas treatment presented #ASCO23. Promising data for #angiosarcoma.
0
4
16
0
636
JournalCancer's profile picture. An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
ACS Journal Cancer
 @JournalCancer
Oct 10

New & #OpenAccess | 5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue #sarcomas: Results from a prospective trial acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

JournalCancer's tweet image. New & #OpenAccess | 5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue #sarcomas: Results from a prospective trial acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert
0
5
13
4
1K
FadiHaddad_MD's profile picture. Assistant Professor, Leukemia Department MD Anderson Cancer Center, Houston
Fadi Haddad, MD
 @FadiHaddad_MD
Jun 3, 2024

Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️

FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
FadiHaddad_MD's tweet image. Great presentation by @APConley77 from @MDAndersonNews discussing TGF-B blockade by AdAPT-001 in combination with #ICI in #sarcomas 🔹43% clinical benefit >6 mo 🔹mPFS not reached 🔹No erious AEs, all G1-2,mostly flu-like symptoms ⬇️⬇️⬇️
0
8
16
0
966
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Dec 22, 2023

🗒️ #JCO #Review: Soft Tissue #Sarcomas in adolescents & young adults ➡️ brnw.ch/21wFyJP #AYA #AYACSM #scmsm

JCO_ASCO's tweet image. 🗒️ #JCO #Review: Soft Tissue #Sarcomas in adolescents & young adults ➡️ brnw.ch/21wFyJP #AYA #AYACSM #scmsm
0
4
23
9
5K
aecirujanos's profile picture. La Asociación Española de Cirugía es una sociedad médico-científica que tiene como finalidad contribuir al progreso de la cirugía.
aecirujanos
 @aecirujanos
May 10, 2024

Muchas gracias a todos por asistir al #IIIEncuentrohispanolusosarcomas celebrado en Madrid y al I Consenso Iberoamericano de #sarcomas Nos vemos el año próximo en Portugal! @SarcomasAEC @GrupoGeis @SarcomasHGUGM

aecirujanos's tweet image. Muchas gracias a todos por asistir al #IIIEncuentrohispanolusosarcomas celebrado en Madrid y al I Consenso Iberoamericano de #sarcomas Nos vemos el año próximo en Portugal! @SarcomasAEC @GrupoGeis @SarcomasHGUGM
aecirujanos's tweet image. Muchas gracias a todos por asistir al #IIIEncuentrohispanolusosarcomas celebrado en Madrid y al I Consenso Iberoamericano de #sarcomas Nos vemos el año próximo en Portugal! @SarcomasAEC @GrupoGeis @SarcomasHGUGM
0
2
9
0
659

Something went wrong.


Something went wrong.


United States Trends